Search Results
Found 1 results
510(k) Data Aggregation
(68 days)
semiquantitative enzyme linked immunoassay for detecting IgA A class autoantibody to f2 glycoprotein I (B2 GPI) for use as an aid diagnosis of certain autoimmune disease thrombotic in the disorders, such as those secondary to systemic lupus erythematosus (SLE) or other lupus-like disorders.
Not Found
This document is a marketing clearance letter from the FDA for the QUANTA Lite™ B2 GPI IgA ELISA device (K973006). It does not contain any information about acceptance criteria or a study proving the device meets those criteria.
The letter primarily states that the device is substantially equivalent to legally marketed predicate devices, allowing it to be marketed. It also mentions general regulatory requirements and where to get further information.
Therefore, I cannot provide the requested information based on the provided text.
Ask a specific question about this device
Page 1 of 1